MedTrace Logo

Impact of High Flow Therapy on Complications Related to Airway Stenting

NCT06069817 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-02-13

No results posted yet for this study

Summary

The application of HFNC therapy in patients with airway stent, improving both humidification and clearance of the airway secretion, could potentially reduce the risk of mucoid impaction, respiratory infections and granulation. HFNC therapy could be superior to nebulization of normal saline (usual care) in order to keep the stent cleaned, reducing, by inference, the risk of complications, as defined above.

Conditions

  • Airway Obstruction
  • Respiratory Infection
  • Mucus; Plug

Interventions

DEVICE

High flow nasal cannula

home treatment with HFNC after airway stent placement both for malignant and benignant central airway obstruction

DEVICE

nebulized normal saline

home treatment with nebulized normal saline after airway stent placement both for malignant and benignant central airway obstruction

Sponsors & Collaborators

  • Cardarelli Hospital

    lead OTHER

Principal Investigators

  • Giuseppe Failla, MD · Ospedale "Antonio Cardarelli", Naples

  • Nadia Corcione, MD, PhD · Ospedale "Antonio Cardarelli", Naples

  • Alfonso Pecoraro, MD · Ospedale "Antonio Cardarelli", Naples

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2024-11-01
Completion
2024-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06069817 on ClinicalTrials.gov